Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B [Phase 1, Phase 2]

View source ↗

Summary

This entry reports a Phase 1/2 clinical trial using umbilical cord mesenchymal stem cells to treat liver cirrhosis caused by chronic hepatitis B, sponsored by P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Cirrhosis

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Liver Cirrhoses | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION